Cubist Systematic Strategies’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-340,346
| Closed | -$10.1M | – | 4439 |
|
|
2023
Q4 | $10.1M | Buy |
340,346
+313,550
| +1,170% | +$6.24M | 0.07% | 446 |
|
|
2023
Q3 | $425K | Sell |
26,796
-137,978
| -84% | -$2.29M | ﹤0.01% | 2404 |
|
|
2023
Q2 | $3.11M | Buy |
164,774
+153,339
| +1,341% | +$1.81M | 0.02% | 1147 |
|
|
2023
Q1 | $43.9K | Sell |
11,435
-246,337
| -96% | -$1.05M | ﹤0.01% | 3584 |
|
|
2022
Q4 | $1.28M | Sell |
257,772
-102,998
| -29% | -$558K | 0.01% | 2223 |
|
|
2022
Q3 | $1.72M | Buy |
360,770
+128,378
| +55% | +$677K | 0.01% | 2156 |
|
|
2022
Q2 | $1.05M | Buy |
232,392
+92,838
| +67% | +$403K | 0.01% | 2448 |
|
|
2022
Q1 | $664K | Sell |
139,554
-317,733
| -69% | -$1.76M | 0.01% | 2349 |
|
|
2021
Q4 | $3.39M | Buy |
457,287
+375,249
| +457% | +$2.33M | 0.03% | 924 |
|
|
2021
Q3 | $465K | Sell |
82,038
-91,541
| -53% | -$529K | 0.01% | 2082 |
|
|
2021
Q2 | $1.14M | Buy |
173,579
+137,413
| +380% | +$959K | 0.01% | 1466 |
|
|
2021
Q1 | $293K | Sell |
36,166
-153,099
| -81% | -$1.25M | ﹤0.01% | 2267 |
|
|
2020
Q4 | $1.22M | Buy |
189,265
+175,053
| +1,232% | +$1.02M | 0.02% | 1246 |
|
|
2020
Q3 | $51K | Sell |
14,212
-18,802
| -57% | -$75.9K | ﹤0.01% | 2366 |
|
|
2020
Q2 | $152K | Buy |
33,014
+3,049
| +10% | +$13K | ﹤0.01% | 2115 |
|
|
2020
Q1 | $102K | Buy |
29,965
+5,317
| +22% | +$23.2K | ﹤0.01% | 1909 |
|
|
2019
Q4 | $126K | Buy |
24,648
+13,461
| +120% | +$45.7K | ﹤0.01% | 2142 |
|
|
2019
Q3 | $27K | Sell |
11,187
-41,536
| -79% | -$110K | ﹤0.01% | 2103 |
|
|
2019
Q2 | $114K | Sell |
52,723
-5,826
| -10% | -$13.8K | ﹤0.01% | 2206 |
|
|
2019
Q1 | $159K | Buy |
58,549
+18,880
| +48% | +$81.8K | 0.01% | 1877 |
|
|
2018
Q4 | $190K | Buy |
39,669
+33,850
| +582% | +$205K | 0.01% | 1564 |
|
|
2018
Q3 | $55K | Sell |
5,819
-3,360
| -37% | -$32.3K | ﹤0.01% | 1697 |
|
|
2018
Q2 | $89K | Sell |
9,179
-2,502
| -21% | -$26.4K | ﹤0.01% | 1571 |
|
|
2018
Q1 | $123K | Sell |
11,681
-47,544
| -80% | -$470K | 0.01% | 1553 |
|
|
2017
Q4 | $380K | Buy |
59,225
+40,526
| +217% | +$250K | 0.02% | 1088 |
|
|
2017
Q3 | $143K | Buy |
+18,699
| New | +$124K | 0.01% | 1550 |
|
Other funds holding IMGN
Cubist Systematic Strategies's IMGN Position: Q1 2024 in Review
Cubist Systematic Strategies sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 340,346 shares — an estimated $10.1M sold.
Cubist Systematic Strategies first reported a position in IMGN in Q3 2017 and held it in 26 quarters. The position peaked at $10.1M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Cubist Systematic Strategies reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 340,346 Immunogen Inc shares in Q1 2024, an estimated $10.1M.
- Cubist Systematic Strategies first reported a position in Immunogen Inc in Q3 2017 and held it in 26 quarters.
- Cubist Systematic Strategies's Immunogen Inc position peaked at $10.1M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.